|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.04 CAD | +12.94% |
|
+27.45% | +64.14% |
| 04:30pm | Satellos Says Interim Phase 2 Data Shows SAT-3247 Improves Muscle Measures in Adult DMD Patients | MT |
| 06-29 | Satellos Bioscience up near 10% as SAT-3247 Granted FDA Fast Track Designation | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bearish | Neutral |
| Resistance | 11.57 | 11.57 | 17.01 |
| Spread/Res. | +12.36% | +12.36% | -23.57% |
| Spread/Supp. | +39.04% | +64.77% | +96.97% |
| Support | 9.35 | 7.89 | 6.6 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MSCL Stock
- Charts Satellos Bioscience Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
